acut
respiratori
diseas
due
viral
infect
common
caus
ill
infant
young
children
around
world
pathophysiolog
vari
upper
airway
obstruct
eg
croup
laryng
laryngotrach
sever
lower
respiratori
tract
ill
eg
pneumon
bronchiol
acut
respiratori
distress
syndrom
burden
respiratori
viral
infect
hospitalis
paediatr
popul
well
describ
howev
limit
publish
data
epidemiolog
outcom
among
critic
ill
children
present
respiratori
viral
infect
admit
paediatr
intens
care
unit
picu
multipl
respiratori
virus
common
hospitalis
children
contrari
one
might
predict
sever
ill
clearli
greater
past
decad
develop
implement
molecular
technolog
field
diagnost
virolog
greatli
enhanc
abil
detect
respiratori
virus
clinic
sampl
exampl
assay
use
revers
transcript
polymeras
chain
reaction
respiratori
pathogen
panel
use
multiplex
pcr
broad
detect
viral
pathogen
incorpor
routin
diagnost
test
mani
laboratori
import
delin
understand
burden
respiratori
viral
infect
differ
outcom
relat
differ
respiratori
virus
identifi
critic
ill
children
establish
manag
strategi
target
futur
research
studi
describ
detect
respiratori
virus
larg
cohort
children
admit
singl
picu
acut
respiratori
diseas
period
examin
associ
endotrach
intub
picu
stay
among
three
commonli
identifi
respiratori
virus
also
compar
need
intub
patient
multipl
virus
versu
one
respiratori
viru
stolleri
children
hospit
picu
patient
age
less
year
western
canadian
refer
centr
larg
catchment
area
includ
central
northern
alberta
surround
region
saskatchewan
british
columbia
well
northwest
territori
nunavut
least
children
year
age
mix
medic
surgic
unit
admiss
per
year
studi
period
includ
post
cardiac
surgeri
patient
annual
admiss
demograph
diagnosi
sever
ill
score
pediatr
risk
mortal
score
iii
prism
iii
treatment
given
picu
stay
picu
hospit
outcom
except
laps
data
collect
collect
administr
databas
wa
usa
primari
diagnos
databas
categoris
categori
secondari
diagnos
code
use
binari
scale
categori
appendic
inclus
criteria
patient
admit
picu
primari
secondari
diagnosi
asthma
reactiv
airway
diseas
pneumoniabronchiol
least
one
search
term
indic
presenc
respiratori
diseas
admiss
appendix
open
label
categori
primari
secondari
diagnos
case
select
use
second
criteria
includ
respiratori
distress
primari
reason
picu
admiss
detect
respiratori
virus
perform
provinci
laboratori
public
health
tempor
chang
respiratori
viru
test
method
algorithm
thu
type
viral
pathogen
detect
studi
period
platform
use
extract
test
data
describ
previous
briefli
three
period
chang
respiratori
viru
target
algorithm
studi
period
novemb
respiratori
syncyti
viru
rsv
parainfluenza
viru
influenza
b
adenoviru
identifi
use
direct
fluoresc
antibodi
dfa
test
rapid
respiratori
cultur
mix
cell
line
dfa
plate
format
novemb
februari
rapid
respiratori
cultur
replac
molecular
diagnost
test
human
metapneumoviru
hmpv
also
detect
sinc
februari
molecular
diagnost
test
replac
rvp
assay
luminex
molecular
diagnost
inc
ontario
canada
rhinovirusenteroviru
four
type
coronaviru
addit
target
origin
six
virus
addit
influenza
b
better
sensit
pandem
influenza
implement
march
prior
march
molecular
diagnost
test
perform
nasopharyng
swab
test
neg
dfa
throat
swab
lower
respiratori
tract
sampl
sinc
march
influenza
b
rvp
assay
perform
sampl
type
regardless
dfa
result
respiratori
viru
test
result
five
day
five
day
date
admiss
picu
includ
analys
picu
admiss
count
independ
event
chang
respiratori
viru
test
algorithm
time
number
admiss
event
use
denomin
calcul
overal
annual
preval
differ
variou
virus
tabl
continu
variabl
distribut
describ
median
interquartil
rang
iqr
differ
treatment
provid
outcom
picu
admiss
includ
picu
length
stay
lo
hospit
lo
picu
hospit
mortal
also
describ
virus
identifi
three
commonli
detect
virus
logist
regress
analys
utilis
viral
detect
exposur
adjust
potenti
confound
variabl
chronic
diseas
prematur
condit
need
endotrach
intub
picu
endotrach
intub
picu
stay
linear
combin
paramet
estim
calcul
interact
term
multipl
viral
detect
might
synergist
effect
outcom
linear
regress
adjust
set
potenti
confound
factor
perform
assess
effect
viru
continu
outcom
picu
lo
hospit
lo
invas
ventil
day
lastli
effect
one
viru
examin
u
test
test
fisher
exact
test
use
compar
continu
nomin
demograph
treatment
variabl
appropri
two
group
regress
analys
adjust
potenti
confound
variabl
repeat
compar
outcom
patient
singl
viru
multipl
virus
less
consid
statist
signific
statist
analys
conduct
stata
version
stata
corp
lp
texa
usa
studi
approv
health
research
ethic
board
univers
alberta
admiss
picu
met
criteria
primari
acut
respiratori
diseas
studi
period
respiratori
viru
test
perform
one
respiratori
virus
detect
among
admiss
children
median
age
year
iqr
year
per
cent
n
admiss
primari
secondari
diagnosi
pneumonia
bronchiol
admiss
median
probabl
death
predict
prism
iii
patient
die
picu
stay
tabl
one
hundr
second
repeat
admiss
primari
singl
hospit
admiss
given
patient
three
preval
respiratori
virus
follow
rhinovirusenteroviru
n
picu
admiss
rsv
n
admiss
parainfluenza
viru
n
admiss
remain
virus
includ
hmpv
admiss
adenoviru
admiss
influenza
viru
admiss
type
coronaviru
admiss
influenza
b
viru
admiss
two
respiratori
virus
detect
admiss
admiss
tabl
fig
hospit
outcom
eight
virus
address
tabl
among
virus
adenoviru
clinic
significantli
higher
endotrach
intub
rate
longer
hospit
lo
day
iqr
focus
three
preval
virus
median
age
picu
admiss
rsv
year
iqr
lower
rhinovirusenteroviru
year
iqr
parainfluenza
viru
year
iqr
regard
clinic
present
apnoea
observ
frequent
rsv
two
virus
symptom
upper
airway
obstruct
ie
croup
laryngotrach
laryng
seen
parainfluenza
viru
significantli
higher
rsv
rhinovirusenteroviru
among
treatment
provid
picu
variabl
use
steroid
among
rhinovirusenteroviru
rsv
parainfluenza
viru
heat
humidifi
nasal
cannula
hhhfnc
also
employ
differ
proport
although
overal
mortal
low
admiss
detect
rhinovirusenteroviru
significantli
higher
mortal
compar
rsv
parainfluenza
p
respect
probabl
requir
endotrach
intub
picu
stay
significantli
higher
admiss
parainfluenza
viru
compar
rsv
ci
absolut
risk
endotrach
intub
rsv
rhinoentero
parainfluenza
respect
tabl
admiss
rhinovirusenteroviru
detect
slightli
longer
invas
ventil
day
compar
rsv
day
p
trend
picu
lo
hospit
lo
longer
rhinovirusenteroviru
compar
rsv
except
hospit
lo
parainfluenza
viru
picu
admiss
two
respiratori
virus
detect
common
combin
rsv
rhinovirusenteroviru
admiss
admiss
median
age
year
iqr
picu
admiss
two
respiratori
virus
detect
significantli
lower
admiss
singl
viru
larger
proport
admiss
multipl
virus
admit
diagnosi
pneumoniabronchiol
multipl
virus
versu
singl
viru
p
antibiot
use
frequent
admiss
multipl
virus
singl
viru
vs
p
wherea
less
steroid
use
admiss
multipl
virus
vs
p
tabl
signific
differ
risk
requir
endotrach
intub
picu
stay
patient
multipl
virus
versu
singl
viru
ci
tabl
differ
number
invas
ventil
day
picu
hospit
lo
mortal
picu
hospit
stay
two
group
tabl
limit
number
studi
evalu
epidemiolog
respiratori
viral
infect
picu
popul
rhinovirusenteroviru
rsv
two
preval
virus
critic
ill
children
admit
acut
respiratori
diseas
picu
similar
recent
studi
although
minor
annual
fluctuat
studi
period
overal
rate
detect
adenoviru
hmpv
respiratori
virus
high
compar
publish
studi
set
potenti
reason
could
relat
inclus
criteria
ie
critic
ill
children
acut
respiratori
diseas
worth
note
year
emerg
pandem
influenza
exclud
analysi
due
miss
data
provid
better
analys
comparison
respiratori
viru
activ
nonpandem
year
compar
clinic
manag
differ
respiratori
virus
risk
intub
admiss
parainfluenza
viru
significantli
higher
admiss
rsv
rhinovirusenteroviru
studi
look
impact
parainfluenza
viru
infect
critic
ill
children
given
sever
ill
differ
significantli
among
three
virus
time
picu
admiss
specif
pathogen
viru
higher
likelihood
laryngotrach
parainfluenza
viru
infect
might
led
higher
rate
endotrach
intub
signific
increas
number
invas
ventil
day
rhinovirusenteroviru
versu
rsv
find
discord
previou
studi
paediatr
cohort
differ
invas
ventil
day
day
cohort
mortal
rate
highest
picu
admiss
detect
rhinovirusenteroviru
import
note
detect
rhinovirusenteroviru
start
novemb
use
rvp
assay
possibl
misclassifi
case
novemb
differenti
rhinoviru
enteroviru
perform
request
clinician
thu
posit
rhinovirusenteroviru
result
includ
broad
rang
virus
gener
caus
mild
upper
respiratori
infect
healthi
popul
retrospect
cohort
studi
includ
patient
admit
picu
respiratori
ill
rhinovirusenteroviru
three
urban
centr
report
mortal
rate
similar
find
retrospect
design
studi
difficult
delin
immedi
direct
caus
death
could
relat
underli
disord
predispos
children
sicker
concomit
viral
infect
observ
trend
picu
admiss
two
respiratori
virus
associ
higher
rate
requir
endotrach
intub
picu
stay
although
statist
signific
also
note
diseas
sever
given
prism
iii
similar
admiss
singl
multipl
virus
detect
abil
identifi
mix
viru
infect
limit
use
molecular
diagnost
test
novemb
case
predomin
viru
detect
dfa
nasopharyng
swab
might
molecular
diagnost
test
perform
prior
march
throat
swab
lower
respiratori
sampl
submit
test
anoth
limit
prism
iii
repres
initi
assess
picu
admiss
higher
rate
antibiot
use
admiss
multipl
virus
might
suggest
patient
present
picu
sever
clinic
pictur
nonetheless
exact
antibiot
indic
could
obtain
databas
recent
perform
systemat
review
conclud
differ
clinic
diseas
sever
singl
infect
respiratori
virus
howev
subgroup
analysi
author
found
higher
mortal
preschool
children
viral
compar
age
group
small
cohort
studi
report
infant
sever
bronchiol
due
higher
odd
admit
picu
singl
viru
studi
domin
combin
virus
rsv
rhinoviru
singl
investig
effect
viral
retrospect
studi
diagnost
panel
includ
rhinovirusenteroviru
report
common
adenoviru
rsv
found
significantli
higher
sever
patient
viral
howev
differ
risk
invas
ventil
requir
icu
lo
observ
differ
find
among
studi
might
relat
differ
demograph
factor
age
underli
sever
limit
studi
admiss
event
respiratori
diseas
select
base
retrospect
review
picu
admiss
diagnosi
thu
popul
like
heterogen
risk
patient
misclassifi
misclassif
would
occur
chang
respiratori
viru
test
algorithm
overtim
fact
patient
subject
molecular
diagnost
test
note
small
number
patient
might
multipl
picu
admiss
due
ill
new
admiss
count
separ
event
analys
detect
viral
pathogen
around
time
admiss
necessarili
repres
causal
relationship
respiratori
symptom
viru
detect
picu
admiss
could
result
chronic
viral
shed
prior
infect
studi
report
associ
acut
respiratori
ill
hospitalis
subsequ
seriou
ill
among
subtyp
howev
enteroviru
contain
mani
speci
viru
picornavirida
famili
group
togeth
diagnost
test
studi
similarli
rsv
versu
rsv
b
parainfluenza
viru
variou
adenovirus
influenza
b
viral
strain
differenti
import
contributor
diseas
sever
secondari
concomit
bacteri
infect
exist
condit
consid
data
analysi
minimis
potenti
bia
antibiot
usag
use
proxi
antibiot
would
start
empir
treatment
final
even
though
studi
one
largest
cohort
picu
set
underpow
evalu
specif
effect
interact
among
variou
virus
possibl
certain
combin
associ
wors
outcom
studi
hospitalis
children
acut
respiratori
infect
vietnam
show
cohort
multipl
viral
infect
rsv
increas
risk
hospitalis
rhinoviru
hmpv
parainfluenza
viru
influenza
viru
type
interact
investig
specif
popul
picu
patient
multicentr
studi
larger
sampl
size
rhinovirusenteroviru
common
respiratori
viral
pathogen
detect
larg
cohort
children
present
acut
respiratori
diseas
admiss
picu
surpass
rsv
main
culprit
risk
endotrach
intub
picu
picu
stay
higher
admiss
parainfluenza
viru
detect
compar
rsv
rhinovirusenteroviru
howev
signific
differ
risk
need
endotrach
intub
picu
stay
patient
multipl
virus
versu
singl
viru
studi
conduct
clarifi
effect
multipl
viral
infect
interact
role
bacteri
paediatr
popul
ak
support
graduat
studentship
award
women
children
health
research
institut
none
author
relev
conflict
interest
declar
none
